viewEuromoney Institutional Investor

Strategic Review and Year End Trading Update

/**/ sup{font-size:80%}h1{margin-top:12.0pt;margin-right:0cm;margin-bottom:13.5pt;margin-left:0cm;font-size:11.0pt;font-family:"Calibri","sans-serif";}h2{margin-top:12.0pt;margin-right:0cm;margin-bottom:13.5pt;margin-left:0cm;font-size:11.0pt;font-family:"Calibri","sans-serif";color:black;font-weight:normal;font-div:italic;}h3{margin-top:2.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Calibri","sans-serif";font-weight:normal;font-div:italic;}h4{margin-top:2.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight:normal;font-div:italic;}h5{margin-top:2.0pt;margin-right:0cm;margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri Light","sans-serif";font-weight:normal;}ol{margin-bottom:0cm;}ul{margin-bottom:0cm;}link{ color: #0563C1 }visited{ color: #954F72 } .db{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 2.0cm 72.0pt;}div.db{}p.cw,li.cw,div.cw{margin-top:0cm;margin-right:0cm;margin-bottom:13.5pt;margin-left:0cm;text-align:center;font-size:11.0pt;font-family:"Calibri","sans-serif";color:black;font-weight:bold;}p.dj{margin-top:0cm;margin-right:0cm;margin-bottom:13.5pt;margin-left:0cm;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify;text-justify:inter-ideograph}p.dk{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify;text-justify:inter-ideograph}p.dl{margin-top:0cm;margin-right:0cm;margin-bottom:13.5pt;margin-left:0cm;text-align:center;font-size:11.0pt;font-family:"Calibri","sans-serif";color:black;font-weight:bold;text-align:justify;text-justify:inter-ideograph}span.dg{font-weight:normal}p.dm{margin-top:0cm;margin-right:0cm;margin-bottom:13.5pt;margin-left:0cm;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;text-align: justify;text-justify:inter-ideograph}span.df{font-size:8.0pt}h1.dd{text-align:justify;text-justify:inter-ideograph} p.dn{margin-top:0cm;margin-right:0cm;margin-bottom:13.5pt;margin-left:0cm;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; text-align: justify; text-justify: inter-ideograph}p.do{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align:justify;text-justify:inter-ideograph}p.dp{margin:0cm;margin-bottom:.0001pt;font-size:11.0pt;font-family:"Calibri","sans-serif";color:black;text-align:justify;text-justify:inter-ideograph}link,span.g{color:#0563C1;text-decoration:underline;} /**/
RNS Number : 2304S
Euromoney Institutional InvestorPLC
05 November 2019

EUROMONEY INSTITUTIONAL INVESTOR PLC ("Euromoney", the "Group" or the "Company")

Strategic Review and Year End Trading Update

5 November 2019

Euromoney, the global information business providing essential B2B information to global and specialist markets, today announces an update on the strategic review announced in September and trading for the year ended 30 September 2019, ahead of the Group's full year results announcement on Thursday 21 November 2019.

On 10 September, Euromoney announced that it was conducting a strategic review of its Asset Management segment made up of the Institutional Investor, BCA Research and NDR businesses. Although still at a relatively early stage, Euromoney confirms that the strategic review is progressing well and the businesses will be reported as discontinued operations and as assets held for sale in the financial statements for the year ended 30 September 2019.


Ahead of the full year results, the Company provides the following trading update1. Full year 2019 results are slightly above the Board's expectations. Adjusted revenue for the year ended 30 September 2019 is expected to be approximately £401m (underlying revenue flat). This reflects a continuation of good growth in the Pricing, Data & Market Intelligence segment, with underlying revenue up approximately 4% and approximately 10% growth in Fastmarkets subscriptions. Asset Management continued to face challenges and saw revenue decline by approximately 4% on an underlying basis. Banking & Finance, our smallest segment which accounted for 15% of the Group's revenues, was down by approximately 1%.  BoardEx has now been fully integrated with strong underlying growth of approximately 11% year-on-year.


Adjusted profit before tax is expected to be approximately £104m, up approximately 9% on an underlying basis, a result that reflects underlying growth in our Pricing, Data & Market Intelligence segment, as well as lower net interest costs.  Cash conversion remains strong at approximately 95%, and year end net cash was approximately £50m. The Company is expected to propose a final dividend in line with last year's final dividend of 22.3p, which would result in a full year dividend of 33.1p per share, up by 2% year on year. 

1. Unaudited results, subject to change.

2. Underlying results above include the adjusted results (which include the results of (a) continuing operations and (b) those operations classified as discontinued in 2019) and restate prior periods using current period exchange rates and use pro-forma comparatives for acquisitions but exclude closed businesses and prior year disposals.  



For further information, please contact:

Euromoney Institutional Investor PLC

Wendy Pallot, Chief Financial Officer: +44 (0)20 7779 8845;

[email protected]

Sarah Cooke, Head of Investor Relations:  +44 (0)20 7779 7363;

[email protected]


FTI Consulting

Charles Palmer / Jamie Ricketts / Amy Hurnell / Jamille Smith +44 20 3727 1000;

[email protected] 

About Euromoney Institutional Investor PLC

Euromoney is a global information business providing essential B2B information to global and specialist markets.  Euromoney provides discovery, market intelligence and events across our segments.  Euromoney is listed on the London Stock Exchange and is a member of the FTSE 250 share index.



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: Euromoney Institutional Investor

Price: 1232

Market: LSE
Market Cap: £1.35 billion

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...